biotechnologie
4 résultats affichés
-
From Novel Biotechnology Platform to Globally Competitive Cancer Company: Proacta Inc.
8,00 $ – 50,00 $CASE STUDY. This decision-based case focuses on whether Proacta should raise more funds within New Zealand alone, syndicate a venture capital round with international investors, or seek a trade sale of the company.
-
U.S. Biotech Industry Note
8,00 $ – 50,00 $INDUSTRY NOTE. Strategy in a typical « biotech » company is determined by the capital markets rather than driven by customers.
-
EntreMed, Inc.: Survival Strategy in the Turbulent Biotech Industry
8,00 $ – 50,00 $CASE STUDY. EntreMed’s new management team needed to revise the overall company strategy to survive.
4 résultats affichés